tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Catherine Novack, 22 are a BUY (91.67%), 2 are a HOLD (8.33%).
Analyst Catherine Novack, currently employed at JONESTRADING, carries an average stock price target met ratio of 30.83% that have a potential upside of 66.24% achieved within 121 days.
Catherine Novack’s has documented 46 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on DYN, Dyne Therapeutics at 08-Dec-2025.
Analyst best performing recommendations are on WVE (WAVE LIFE SCIENCES LTD).
The best stock recommendation documented was for WVE (WAVE LIFE SCIENCES LTD) at 8/9/2024. The price target of $12 was fulfilled within 68 days with a profit of $6.59 (121.81%) receiving and performance score of 17.91.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-Dec-2020
$12
2 months 6 days ago
(02-Dec-2025)
0/5 (0%)
$9.1 (313.79%)
Buy Since 04-Sep-2025
$8
$6.31 (373.37%)
5 months 4 days ago
(04-Sep-2025)
1/2 (50%)
$5.87 (275.59%)
660
Buy Since 16-Aug-2024
$13
$11.31 (669.23%)
1 years 5 months 23 days ago
(16-Aug-2024)
0/1 (0%)
$9.43 (264.15%)
Buy
$3
$0.09 (3.09%)
1 years 8 months 25 days ago
(15-May-2024)
2/2 (100%)
$-1.32 (-30.56%)
135
Buy Since 30-Aug-2023
$2
$0.31 (18.34%)
2 years 5 months 9 days ago
(30-Aug-2023)
1/1 (100%)
$-6.52 (-76.53%)
709
Which stock is Catherine Novack is most bullish on?
Which stock is Catherine Novack is most reserved on?
What Year was the first public recommendation made by Catherine Novack?
